Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

Cell identity and nucleo-mitochondrial genetic context modulate OXPHOS performance and determine somatic heteroplasmy dynamics.

  • Lechuga-Vieco, Ana V.
  • Latorre-Pellicer, Ana
  • Johnston, Iain G
  • Prota, Gennaro
  • Gileadi, Uzi
  • Justo-Mendez, Raquel
  • Acin-Perez, Rebeca
  • Martínez-de-Mena, Raquel
  • Fernandez-Toro, Jose Maria
  • Jimenez-Blasco, Daniel
  • Mora, Alfonso
  • Nicolas-Avila, Jose A.
  • Santiago, Demetrio J
  • Priori, Silvia G.
  • Bolaños, Juan Pedro
  • Sabio, Guadalupe
  • Criado-Rodriguez, Luis M.
  • Ruiz-Cabello, Jesus
  • Cerundolo, Vincenzo
  • Jones, Nick S
  • Enriquez, Jose Antonio
Heteroplasmy, multiple variants of mitochondrial DNA (mtDNA) in the same cytoplasm, may be naturally generated by mutations but is counteracted by a genetic mtDNA bottleneck during oocyte development. Engineered heteroplasmic mice with nonpathological mtDNA variants reveal a nonrandom tissue-specific mtDNA segregation pattern, with few tissues that do not show segregation. The driving force for this dynamic complex pattern has remained unexplained for decades, challenging our understanding of this fundamental biological problem and hindering clinical planning for inherited diseases. Here, we demonstrate that the nonrandom mtDNA segregation is an intracellular process based on organelle selection. This cell type-specific decision arises jointly from the impact of mtDNA haplotypes on the oxidative phosphorylation (OXPHOS) system and the cell metabolic requirements and is strongly sensitive to the nuclear context and to environmental cues.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cell identity and nucleo-mitochondrial genetic context modulate OXPHOS performance and determine somatic heteroplasmy dynamics

  • Lechuga-Vieco, Ana V.
  • Latorre-Pellicer, Ana
  • Johnston, Iain G.
  • Prota, Gennaro
  • Gileadi, Uzi
  • Justo-Méndez, Raquel
  • Acín-Pérez, Rebeca
  • Martínez-De-Mena, Raquel
  • Fernández-Toro, José María
  • Jimenez-Blasco, Daniel
  • Mora, Alfonso
  • Nicolás-Ávila, José A.
  • Santiago, Demetrio J.
  • Priori, Silvia G.
  • Bolaños, Juan P.
  • Sabio, Guadalupe
  • Criado, Luis M.
  • Ruiz-Cabello, Jesús
  • Cerundolo, Vincenzo
  • Jones, Nick S.
  • Enríquez, José Antonio
Heteroplasmy, multiple variants of mitochondrial DNA (mtDNA) in the same cytoplasm, may be naturally generated by mutations but is counteracted by a genetic mtDNA bottleneck during oocyte development. Engineered heteroplasmic mice with nonpathological mtDNA variants reveal a nonrandom tissue-specific mtDNA segregation pattern, with few tissues that do not show segregation. The driving force for this dynamic complex pattern has remained unexplained for decades, challenging our understanding of this fundamental biological problem and hindering clinical planning for inherited diseases. Here, we demonstrate that the nonrandom mtDNA segregation is an intracellular process based on organelle selection. This cell type-specific decision arises jointly from the impact of mtDNA haplotypes on the oxidative phosphorylation (OXPHOS) system and the cell metabolic requirements and is strongly sensitive to the nuclear context and to environmental cues., This study was supported by MINECO SAF2015-65633-R to JAE, SAF2016-78114-R to J.P.B. and SAF2017- 84494-C2-1-R to J.R.-C. G.S. thanks MINECO-FEDER SAF2016-79126-R and Comunidad de Madrid IMMUNOTHERCAN-CM B2017/BMD-3733. N.S.J. thanks EP/N014529/1. CIBERFES (CB16/10/00282) to J.P.B. and J.A.E., and H2020 European Commission (BatCure grant 666918) to J.P.B. A.V.L.-V. was supported by SOFPI-fellowship from the MINECO. V.C. is supported by the UK Medical Research Council, Cancer Research UK (CRUK) (C399/A2291), and the Oxford Biomedical Research Centre. I.G.J. thanks the European Research Council (ERC- No. 805046-EvoConBiO). The CNIC is supported by MINECO and Pro-CNIC Foundation and is a SO-MINECO (award SEV-2015-0505). CIC biomaGUNE is supported by the Maria de Maeztu Units of Excellence Program from the Spanish State Research Agency (grant no. MDM-2017- 0720), ELKARTEK Program (grant no. KK-2019/bmG19), and BBVA Foundation (Ayudas a Equipos de investigación científica Biomedicina 2018)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

HyperTraPS-CT: Inference and prediction for accumulation pathways with flexible data and model structures

  • Aga, Olav N. L.
  • Brun, Morten
  • Dauda, Kazeem A.
  • Díaz-Uriarte, Ramón
  • Giannakis, Konstantinos
  • Johnston, Iain G.
Accumulation processes, where many potentially coupled features are acquired over time, occur throughout the sciences from evolutionary biology to disease progression, and particularly in the study of cancer progression. Existing methods for learning the dynamics of such systems typically assume limited (often pairwise) relationships between feature subsets, cross-sectional or untimed observations, small feature sets, or discrete orderings of events. Here we introduce HyperTraPS-CT (Hypercubic Transition Path Sampling in Continuous Time) to compute posterior distributions on continuous-time dynamics of many, arbitrarily coupled, traits in unrestricted state spaces, accounting for uncertainty in observations and their timings. We demonstrate the capacity of HyperTraPS-CT to deal with cross-sectional, longitudinal, and phylogenetic data, which may have no, uncertain, or precisely specified sampling times. HyperTraPS-CT allows positive and negative interactions between arbitrary subsets of features (not limited to pairwise interactions), supporting Bayesian and maximum-likelihood inference approaches to identify these interactions, consequent pathways, and predictions of future and unobserved features. We also introduce a range of visualisations for the inferred outputs of these processes and demonstrate model selection and regularisation for feature interactions. We apply this approach to case studies on the accumulation of mutations in cancer progression and the acquisition of anti-microbial resistance genes in tuberculosis, demonstrating its flexibility and capacity to produce predictions aligned with applied priorities., This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (Grant agreement No. 805046 (EvoConBiO) to IGJ). This work was supported by the Trond Mohn Foundation [project HyperEvol under grant agreement No. TMS2021TMT09 to IGJ], through the Centre for Antimicrobial Resistance in Western Norway (CAMRIA) [TMS2020TMT11]. RDU was partially supported by grant PID2019-111256RB-I00 funded by MCIN/AEI/10.13039/501100011033., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A hypercubic Mk model framework for capturing reversibility in disease, cancer, and evolutionary accumulation modelling

  • Johnston, Iain G.
  • Díaz-Uriarte, Ramón
[Motivation]: Accumulation models, where a system progressively acquires binary features over time, are common in the study of cancer progression, evolutionary biology, and other fields. Many approaches have been developed to infer the accumulation pathways by which features (e.g. mutations) are acquired over time. However, most of these approaches do not support reversibility: the loss of a feature once it has been acquired (e.g. the clearing of a mutation from a tumor or population)., [Results]: Here, we demonstrate how the well-established Mk model from evolutionary biology, embedded on a hypercubic transition graph, can be used to infer the dynamics of accumulation processes, including the possibility of reversible transitions, from data which may be uncertain and cross-sectional, longitudinal, or phylogenetically/phylogenomically embedded. Positive and negative interactions between arbitrary sets of features (not limited to pairwise interactions) are supported. We demonstrate this approach with synthetic datasets and real data on bacterial drug resistance and cancer progression. While this implementation is limited in the number of features that can be considered, we discuss how this limitation may be relaxed to deal with larger systems., This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 Research and Innovation Programme [Grant agreement No. 805046 (EvoConBiO) to I.G.J.]. I.G.J. was supported by the Trond Mohn Foundation [project HyperEvol under grant agreement No. TMS2021TMT09], through the Centre for Antimicrobial Resistance in Western Norway (CAMRIA) [TMS2020TMT11]. R.D.U. was supported by grant PID2019-111256RB-I00 funded by MCIN/AEI/10.13039/501100011033., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Picture Guide to Cancer Progression and Evolutionary Accumulation Models: Systematic Critique, Plausible Interpretations, and Alternative Uses

  • Díaz-Uriarte, Ramón
  • Johnston, Iain G.
Cancer progression and evolutionary accumulation models were developed to discover dependencies in the irreversible acquisition of binary traits from cross-sectional data. They have been used in oncology and virology but also in widely different problems such as malaria progression. These methods have been applied to predict future states of the system, identify routes of feature acquisition, and improve patient stratification, and they hold promise for evolutionary-based treatments. New methods continue to be developed. But these methods have shortcomings, which are yet to be systematically critiqued, regarding key evolutionary assumptions and interpretations. After an overview of available methods, we focus on why inferences might not be about the processes we intend. Using fitness landscapes, we highlight difficulties arising from bulk sequencing, from conflating lines of descent, path of the maximum, and mutational profiles, and from the idea of exclusivity. We show that bulk sequencing can severely limit interpretation as inferring within-cell restrictions is only warranted under very strong assumptions. We suggest that limitations and opportunities from bulk sequencing be recognised and exploited explicitly; the methods remain valuable for patient stratification, and we underline opportunities for addressing dependencies due to frequencydependent selection. This review identifies major standing issues, recommends turning inferences into actionable insights for translational impact —which requires careful consideration of empirical entities for causally-justified interpretations—, assessing method performance with entity-appropriate simulations, and should encourage the use of these methods in other areas with a better alignment between entities and model assumptions., MCIN/AEI/10.13039/501100011033 (Grant Number: PID2019-111256RB-I00) Trond Mohn Foundation, project HyperEvol (Grant Number: TMS2021TMT09) Centre for Antimicrobial Resistance in Western Norway (CAMRIA) (Grant Number: TMS2020TMT11) European Research Council (ERC) through the European Union’s Horizon 2020 Research and Innovation Program (Grant Number: 805046 (EvoConBiO)), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Evolutionary accumulation modeling in AMR: machine learning to infer and predict evolutionary dynamics of multi-drug resistance

  • Renz, Jessica
  • Dauda, Kazeem A.
  • Aga, Olav N. L.
  • Díaz-Uriarte, Ramón
  • Löhr, Iren H.
  • Blomberg, Bjørn
  • Johnston, Iain G.
© 2025 Renz et al., Can we understand and predict the evolutionary pathways by which bacteria acquire multi-drug resistance (MDR)? These questions have substantial potential impact in basic biology and in applied approaches to address the global health challenge of antimicrobial resistance (AMR). In this minireview, we discuss how a class of machine-learning approaches called evolutionary accumulation modeling (EvAM) may help reveal these dynamics using genetic and/or phenotypic AMR data sets, without requiring longitudinal sampling. These approaches are well-established in cancer progression and evolutionary biology but currently less used in AMR research. We discuss how EvAM can learn the evolutionary pathways by which drug resistances and other AMR features (for example, mutations driving these resistances) are acquired as pathogens evolve, predict next evolutionary steps, identify influences between AMR features, and explore differences in MDR evolution between regions, demographics, and more. We demonstrate a case study from the literature on MDR evolution in Mycobacterium tuberculosis and discuss the strengths and weaknesses of these approaches, providing links to some approaches for implementation., This work was supported by the Trond Mohn Foundation (project HyperEvol under grant agreement No. TMS2021TMT09 to I.G.J.) through the Centre for Antimicrobial Resistance in Western Norway (CAMRIA) (TMS2020TMT11). This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement No. 805046 [EvoConBiO] to I.G.J). This research was supported by grant PID2019-111256RB-I00 funded by MCIN/AEI/10.13039/501100011033 to Ramon Diaz-Uriarte., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Cell identity and nucleo-mitochondrial genetic context modulate OXPHOS performance and determine somatic heteroplasmy dynamics

  • Lechuga-Vieco, A.V.
  • Latorre-Pellicer, A.
  • Johnston, I.G.
  • Prota, G.
  • Gileadi, U.
  • Justo-Méndez, R.
  • Acín-Pérez, R.
  • Martínez-de-Mena, R.
  • Fernández-Toro, J.M.
  • Jimenez-Blasco, D.
  • Mora, A.
  • Nicolás-Ávila, J.A.
  • Santiago, D.J.
  • Priori, S.G.
  • Bolaños, J.P.
  • Sabio, G.
  • Criado, L.M.
  • Ruíz-Cabello, J.
  • Cerundolo, V.
  • Jones, N.S.
  • Enríquez, J.A.
Heteroplasmy, multiple variants of mitochondrial DNA (mtDNA) in the same cytoplasm, may be naturally generated by mutations but is counteracted by a genetic mtDNA bottleneck during oocyte development. Engineered heteroplasmic mice with nonpathological mtDNA variants reveal a nonrandom tissue-specific mtDNA segregation pattern, with few tissues that do not show segregation. The driving force for this dynamic complex pattern has remained unexplained for decades, challenging our understanding of this fundamental biological problem and hindering clinical planning for inherited diseases. Here, we demonstrate that the nonrandom mtDNA segregation is an intracellular process based on organelle selection. This cell type-specific decision arises jointly from the impact of mtDNA haplotypes on the oxidative phosphorylation (OXPHOS) system and the cell metabolic requirements and is strongly sensitive to the nuclear context and to environmental cues.